Issue 5/1999
Content (8 Articles)
Leading Article
Prescribing at the Interface Between Primary and Secondary Care in the UK
Martin Duerden, Tom Walley
Review Article
Counting the Costs of Drug-Related Adverse Events
T. Jeffrey White, Annet Arakelian, Jay P. Rho
Review Article
The Revised Canadian Guidelines for the Economic Evaluation of Pharmaceuticals
Dr Judith L. Glennie, George W. Torrance, Jean François Baladi, Catherine Berka, Eleanor Hubbard, Devidas Menon, Nick Otten, Marc Rivière
Original Research Article
Clinical and Economic Outcomes of Olanzapine Compared With Haloperidol for Schizophrenia
Susan H. Hamilton, Dennis A. Revicki, Eric T. Edgell, Laura A. Genduso, Gary Tollefson
Original Research Article
Reconciling Decision Models With the Real World
Ya-Chen Tina Shih, Teresa L. Kauf
Original Research Article
Medical Resource Use and Cost of Venlafaxine or Tricyclic Antidepressant Therapy
Robert I. Griffiths, Erin M. Sullivan, Richard G. Frank, Michael J. Strauss, Robert J. Herbert, Jon Clouse, Howard H. Goldman
Original Research Article
Direct Costs of Hip Fractures in Patients Over 60 Years of Age in Belgium
Jean-Yves Reginster, Pierre Gillet, Wafa Ben Sedrine, Geoffrey Brands, Olivier Ethgen, Cécile de Froidmont, Christiane Gosset